241 related articles for article (PubMed ID: 20952594)
1. Angiopoietin-2-driven vascular remodeling in airway inflammation.
Tabruyn SP; Colton K; Morisada T; Fuxe J; Wiegand SJ; Thurston G; Coyle AJ; Connor J; McDonald DM
Am J Pathol; 2010 Dec; 177(6):3233-43. PubMed ID: 20952594
[TBL] [Abstract][Full Text] [Related]
2. Angiopoietin/Tie2 signaling transforms capillaries into venules primed for leukocyte trafficking in airway inflammation.
Fuxe J; Lashnits E; O'Brien S; Baluk P; Tabruyn SP; Kuhnert F; Kuo C; Thurston G; McDonald DM
Am J Pathol; 2010 Apr; 176(4):2009-18. PubMed ID: 20133818
[TBL] [Abstract][Full Text] [Related]
3. Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation.
Kim M; Allen B; Korhonen EA; Nitschké M; Yang HW; Baluk P; Saharinen P; Alitalo K; Daly C; Thurston G; McDonald DM
J Clin Invest; 2016 Sep; 126(9):3511-25. PubMed ID: 27548529
[TBL] [Abstract][Full Text] [Related]
4. Synergistic actions of blocking angiopoietin-2 and tumor necrosis factor-α in suppressing remodeling of blood vessels and lymphatics in airway inflammation.
Le CT; Laidlaw G; Morehouse CA; Naiman B; Brohawn P; Mustelin T; Connor JR; McDonald DM
Am J Pathol; 2015 Nov; 185(11):2949-68. PubMed ID: 26348576
[TBL] [Abstract][Full Text] [Related]
5. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization.
Asahara T; Chen D; Takahashi T; Fujikawa K; Kearney M; Magner M; Yancopoulos GD; Isner JM
Circ Res; 1998 Aug; 83(3):233-40. PubMed ID: 9710115
[TBL] [Abstract][Full Text] [Related]
6. Tie1 controls angiopoietin function in vascular remodeling and inflammation.
Korhonen EA; Lampinen A; Giri H; Anisimov A; Kim M; Allen B; Fang S; D'Amico G; Sipilä TJ; Lohela M; Strandin T; Vaheri A; Ylä-Herttuala S; Koh GY; McDonald DM; Alitalo K; Saharinen P
J Clin Invest; 2016 Sep; 126(9):3495-510. PubMed ID: 27548530
[TBL] [Abstract][Full Text] [Related]
7. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.
Maisonpierre PC; Suri C; Jones PF; Bartunkova S; Wiegand SJ; Radziejewski C; Compton D; McClain J; Aldrich TH; Papadopoulos N; Daly TJ; Davis S; Sato TN; Yancopoulos GD
Science; 1997 Jul; 277(5322):55-60. PubMed ID: 9204896
[TBL] [Abstract][Full Text] [Related]
8. Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2.
Teichert-Kuliszewska K; Maisonpierre PC; Jones N; Campbell AI; Master Z; Bendeck MP; Alitalo K; Dumont DJ; Yancopoulos GD; Stewart DJ
Cardiovasc Res; 2001 Feb; 49(3):659-70. PubMed ID: 11166279
[TBL] [Abstract][Full Text] [Related]
9. Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels.
Falcón BL; Hashizume H; Koumoutsakos P; Chou J; Bready JV; Coxon A; Oliner JD; McDonald DM
Am J Pathol; 2009 Nov; 175(5):2159-70. PubMed ID: 19815705
[TBL] [Abstract][Full Text] [Related]
10. Ligand oligomerization state controls Tie2 receptor trafficking and angiopoietin-2-specific responses.
Pietilä R; Nätynki M; Tammela T; Kangas J; Pulkki KH; Limaye N; Vikkula M; Koh GY; Saharinen P; Alitalo K; Eklund L
J Cell Sci; 2012 May; 125(Pt 9):2212-23. PubMed ID: 22357955
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
12. Pericyte requirement for anti-leak action of angiopoietin-1 and vascular remodeling in sustained inflammation.
Fuxe J; Tabruyn S; Colton K; Zaid H; Adams A; Baluk P; Lashnits E; Morisada T; Le T; O'Brien S; Epstein DM; Koh GY; McDonald DM
Am J Pathol; 2011 Jun; 178(6):2897-909. PubMed ID: 21550017
[TBL] [Abstract][Full Text] [Related]
13. Expression and function of Angiopoietins and their tie receptors in human basophils and mast cells.
Prevete N; Staiano RI; Granata F; Detoraki A; Necchi V; Ricci V; Triggiani M; De Paulis A; Marone G; Genovese A
J Biol Regul Homeost Agents; 2013; 27(3):827-39. PubMed ID: 24152847
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of angiopoietins and Tie2 in the lungs of chronic asthmatic mice.
Makinde TO; Agrawal DK
Am J Respir Cell Mol Biol; 2011 Mar; 44(3):384-93. PubMed ID: 20463289
[TBL] [Abstract][Full Text] [Related]
15. Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology.
Akwii RG; Sajib MS; Zahra FT; Mikelis CM
Cells; 2019 May; 8(5):. PubMed ID: 31108880
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil dependence of vascular remodeling after Mycoplasma infection of mouse airways.
Baluk P; Phillips K; Yao LC; Adams A; Nitschké M; McDonald DM
Am J Pathol; 2014 Jun; 184(6):1877-89. PubMed ID: 24726646
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium.
Yuan HT; Khankin EV; Karumanchi SA; Parikh SM
Mol Cell Biol; 2009 Apr; 29(8):2011-22. PubMed ID: 19223473
[TBL] [Abstract][Full Text] [Related]
18. The complex role of angiopoietin-2 in the angiopoietin-tie signaling pathway.
Thurston G; Daly C
Cold Spring Harb Perspect Med; 2012 Sep; 2(9):a006550. PubMed ID: 22951441
[TBL] [Abstract][Full Text] [Related]
19. Suppression of Ocular Vascular Inflammation through Peptide-Mediated Activation of Angiopoietin-Tie2 Signaling.
Mirando AC; Lima E Silva R; Chu Z; Campochiaro PA; Pandey NB; Popel AS
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708100
[TBL] [Abstract][Full Text] [Related]
20. Expression of angiopoietin-1, angiopoietin-2, and Tie2 genes in normal ovary with corpus luteum and in ovarian cancer.
Hata K; Udagawa J; Fujiwaki R; Nakayama K; Otani H; Miyazaki K
Oncology; 2002; 62(4):340-8. PubMed ID: 12138242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
